DEXTROSE INJECTION
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded a delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) for the procurement of DEXTROSE INJECTION, identified by NSN 6505013318941 and PR 7017713199. The total contract value is $270.70, with the award issued on July 31, 2026, under solicitation number SPE2DP26F8564. This transaction is classified as a federal award and is part of the Department of Defense’s procurement activities. The order is for a single line item of medical injectable solution, likely intended for military or federal healthcare use. Place of performance and point of contact information are not specified in the available data, and no set-aside designation or NAICS code is provided. The award is accessible through the DIBBS portal via the provided UI link.
General Info
Contract Value
$270.7Place of Performance
Not specifiedSet-Aside
Awardee
DMS PHARMACEUTICAL GROUP INCAward Issued Date
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
